Effient and Plaquenil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effient (prasugrel hydrochloride) and Plaquenil (hydroxychloroquine sulfate). Common drug interactions include nausea among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Effient and Plaquenil. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 91,018 Plaquenil users. Check the latest studies of Plaquenil.

On Jul, 07, 2026

26 people who take Effient and Plaquenil together, and have interactions are studied.

Effient and Plaquenil drug interactions.

What are the common drug interactions of Effient and Plaquenil, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Drug ineffective
Fall
Acne (skin problems that cause pimples)
Humerus fracture (injury to the upper arm bone)
Inflammation
Injection site bruising
Injection site pain
Intestinal perforation (complete penetration of the wall of the intestine)
Oedema (fluid collection in tissue)

male:

Abdominal pain
Amylase increased
Vomiting
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Burning sensation
Epistaxis (bleed from the nose)
Erythema (redness of the skin)
Flushing (the warm, red condition of human skin)
Hypertension (high blood pressure)
Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Effient and Plaquenil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Fall
Humerus fracture (injury to the upper arm bone)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cardiac disorder
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Dizziness
Fatigue (feeling of tiredness)
Infection
Injection site bruising

60+:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Rash
Scab (a hard coating on the skin formed during the wound healing)
Mallet finger (a deformity of a finger caused when a certain tendon (the extensor tendon) is damaged)
Pneumonia legionella (pneumonia caused by the bacteria legionella)
Synovitis (inflammation of the synovial membrane)
Benign neoplasm (benign (non-cancerous) tumour)
Bladder mass
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 65.38%
Pain: 3 people, 11.54%
Diabetes: 3 people, 11.54%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.69%
Insomnia (sleeplessness): 2 people, 7.69%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 7.69%
High Blood Cholesterol: 2 people, 7.69%
Depression: 2 people, 7.69%
Cardiac Disorder: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Effient and Plaquenil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously